THE CYP2D6 'ENHANCER' SNP: LONG-RANGE LINKAGE ANALYSIS AND IMPACT ON ACTIVITY IN HUMAN LIVER TISSUE

被引：0
|
作者：
Gaedigk, Andrea [1 ]
Boone, Erin C. [1 ]
Dinh, Jean C. [1 ]
Gaedigk, Roger [1 ]
Lata, Ryan F. [1 ]
Pearce, Robin E. [1 ]
Wang, Wendy Y. [1 ]
Miller, Neil A. [1 ]
Staggs, Vincent S. [1 ]
Leeder, J. Steven [1 ]
机构：
[1] Childrens Mercy Kansas City, Kansas City, MO USA
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2020年 / 35卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P191
引用
收藏
页码：S80 / S81
页数：3
相关论文
共 50 条
  • [21] Comprehensive analysis of CYP2D6 mutations in human cancers
    Kuchinski, Kennedy
    Driggers, Julia
    Vo, Martin
    Escorcia, Wilber
    Wetzel, Hanna
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [22] CYP2D6 in the Brain: Impact on Suicidality
    Stingl, J. C.
    Viviani, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (03) : 352 - 353
  • [23] A frequent CYP2D6 variant promotes skipping of exon 3 and reduces CYP2D6 protein expression in human liver samples
    Collins, Joseph M. M.
    Lester, Hannah
    Shabnaz, Samia
    Wang, Danxin
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [24] The influence of clomipramine on CYP2D6 activity
    Szewczuk-Boguslawska, Monika
    Kiejna, Andrzej
    Grzesiak, Magdalena
    Beszlej, Jan Aleksander
    Chlebowska, Iwona
    Orzechowska-Juzwenko, Krystyna
    Milejski, Piotr
    PSYCHIATRIA POLSKA, 2007, 41 (02) : 243 - 249
  • [25] The Activity of Human CYP2D6 in Low Water Organic Solvents
    Zhao, Jin
    Auclair, Karine
    BIOTECHNOLOGY AND BIOENGINEERING, 2009, 102 (04) : 1268 - 1272
  • [26] Inhibition of CYP2D6 activity by bupropion
    Kotlyar, M
    Brauer, LH
    Tracy, TS
    Hatsukami, DK
    Harris, J
    Bronars, CA
    Adson, DE
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (03) : 226 - 229
  • [27] Formation of glutathione adduct metabolites of MDA in human liver microsomes is related to CYP2D6 activity
    Easton, N
    O'Shea, E
    Kingston, S
    Fry, JR
    Marsden, CA
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 : U97 - U97
  • [28] Nomenclature for human CYP2D6 alleles
    Daly, AK
    Brockmoller, J
    Broly, F
    Eichelbaum, M
    Evans, WE
    Gonzalez, FJ
    Huang, JD
    Idle, JR
    IngelmanSundberg, M
    Ishizaki, T
    JacqzAigrain, E
    Meyer, UA
    Nebert, DW
    Steen, VM
    Wolf, CR
    Zanger, UM
    PHARMACOGENETICS, 1996, 6 (03): : 193 - 201
  • [29] Loss of CYP2D6 activity sensitizes liver cancer cells to chemotherapy
    Rameika, N.
    Zhang, X.
    Zhong, L.
    Rendo, V.
    Kundu, S.
    Nuciforo, S.
    Stoimenov, I.
    Ljungstrom, V.
    Heim, M. H.
    Globisch, D.
    Sjoblom, T.
    ANNALS OF ONCOLOGY, 2023, 34 : S1179 - S1179
  • [30] Metabolism of pimozide by CYP3A and CYP2D6 in human liver microsomes.
    Flockhart, DA
    Richard, E
    Soukova, N
    Kerbusch, T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PIV65 - PIV65
12345